BCL2 and neuroblastoma: Here, we provide the first side-by-side comparison of ABT-199, S63845 and A1331852 in neuroblastoma cell lines and primary-derived cultures and find that all three antiapoptotic BCL-2 proteins are relevant therapeutic targets.